Integra LifeSciences launches coral cobalt chrome rods

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Philips, Masimo Extend Partnership to Sensor...

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series...

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

Integra LifeSciences Holdings Corporation announced the launch of 5.5mm Coral(TM) cobalt chrome rods in a range of lengths for use in spinal correction and fusion procedures. With the addition of cobalt chrome rods, the Coral(TM) Spinal System now offers three rod options, which also include rigid and malleable titanium rods.

By offering a range of rod options, the surgeon can now make intra-operative decisions on rod rigidity after the placement of spinal screws. The unique properties of cobalt chrome alloy make the new rods stiffer than the titanium rods currently offered in the Coral(TM) Spinal System. The increased stiffness helps maintain spinal correction under heavier loads without compromising imaging capabilities. In addition, cobalt chrome rods have minimal spring back capability, thereby reducing the need to over bend the rods when adjusting them for specific curve correction.

Randy Theken, President of Integra Spine said, We are very pleased to add cobalt chrome rods to our Coral(TM) Spinal System, which will give the surgeon broader options when treating the patient.

In 2007, the largest of all three segments in the U.S. spinal fusion market (cervical, interbody and thoracolumbar) was the traditional thoracolumbar implant market, consisting of devices used in thoracolumbar fusions for degenerative, deformity, and trauma/tumor conditions. Valued at over $1.9 billion in 2007, the traditional thoracolumbar implant market is expected to grow steadily. Many thoracolumbar procedures may be performed using a pedicle screw system such as the Coral(TM) Spinal System.

Latest stories

Related stories

Philips, Masimo Extend Partnership to Sensor Technologies

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series D Funding by JJDC

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back